EGFR and non-small cell lung carcinoma: In recent years, increasing interest has been focused on identifying effective biomarkers for early diagnosis and therapeutic targets for NSCLC treatment; such biomarkers and targets include EGFR, KRAS, PD‐1, VEGF, BRAF, and HER‐2.6, 7, 8, 9, 10, 11